Gen-Probe Incorporated (NASDAQ: GPRO)

Sector: Medical

Current Price : $82.69

52 Week Low
$54.0852 Week High
$82.69

Press Releases
Gen-Probe Receives Stockholder Approval For Proposed Merger With Hologic
SolarWinds Inc. to Join S&P MidCap 400; HealthStream Inc. to Join the S&P SmallCap 600
Gen-Probe and Life Technologies to Co-Distribute SeCore? HLA Sequence-Based Typing Products
Hologic Announces Pricing Of Financing In Connection With Acquisition Of Gen-Probe
Hologic And Gen-Probe Provide Update On Pending Transaction
Hologic, Inc. Announces Note Offering
Hologic and Gen-Probe Announce Expiration of Hart-Scott-Rodino Act Waiting Period
FDA Clears Gen-Probe's PANTHER? System for use with APTIMA Combo 2? Assay
Gen-Probe Withdraws from Previously Announced Investor Presentations
Faruqi & Faruqi, LLP Announces Investigation of Gen-Probe Inc.
Gen-Probe Buyout: The Securities Attorneys at The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of the Acquisition of Gen-Probe, Inc. by Hologic, Inc.
Ryan & Maniskas, LLP Announces Investigation of Gen-Probe Inc.
Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Gen-Probe, Inc.
Law Office of Brodsky & Smith, LLC Announces Investigation of Gen-Probe Incorporated
Law Offices of Howard G. Smith Announces Investigation of Gen-Probe Inc.
The Law Firm of Weiss & Lurie Investigates Gen-Probe Inc.
San Diego Law Firm Robbins Umeda LLP Announces an Investigation of Gen-Probe Incorporated
Harwood Feffer LLP Announces Investigation of Gen-Probe, Inc.
Gen-Probe Inc. Board of Directors Under Investigation for Potential Breaches of Fiduciary Duty by Glancy Binkow & Goldberg LLP
Law Firm Brower Piven Announces Investigation in Connection With the Acquisition of Gen-Probe Incorporated by Hologic, Inc.
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Gen-Probe Incorporated
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
Kendall Law Group Investigates Gen-Probe Inc.
Gen-Probe Incorporated (GPRO) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition by Hologic, Inc.
4 Active Stocks on Traders' Radar Screens for 04/30/12: BMSN, BKS, GPRO, SEFE
Buyout Of Gen-Probe - Shareholder Investigation By Tripp Levy PLLC On Behalf Of Gen-Probe Shareholders
Hologic to Acquire Gen-Probe
Gen-Probe Announces Webcast of First Quarter 2012 Earnings Conference Call
Gen-Probe Announces Key Executive Promotions and Additions
Gen-Probe to Webcast Four Upcoming Investor Presentations
FDA Approves Gen-Probe's PROGENSA? PCA3 Assay, First Urine-Based Molecular Test to Help Determine Need for Repeat Prostate Biopsies
Gen-Probe to Webcast Two Upcoming Investor Presentations
Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2011 Earnings Conference Call
Gen-Probe to Webcast Presentation at the Oppenheimer 22nd Annual Healthcare Conference
Hank Nordhoff to Retire from Gen-Probe
Gen-Probe to Webcast Three Upcoming Investor Presentations
Gen-Probe Announces Webcast of Third Quarter 2011 Earnings Conference Call
Gen-Probe to Webcast Three Upcoming Investor Presentations
Gen-Probe Receives Canadian Regulatory Clearance for PANTHER? System, Fully Automated and Integrated Molecular Testing Instrument
Gen-Probe Receives Canadian Regulatory Approval for PROGENSA(R) PCA3 Assay, New Molecular Urine Test to Help Determine Need for Repeat Prostate Biopsies
Gen-Probe to Webcast Two Upcoming Investor Presentations
Roka Bioscience Completes $20 Million Series C Financing
Gen-Probe to Webcast Presentation at the William Blair & Company 31st Annual Growth Stock Conference
Gen-Probe to Webcast Two Upcoming Investor Presentations
Gen-Probe Files for US Regulatory Clearance of PANTHER(tm) System, Fully Automated and Integrated Molecular Testing Instrument
Gen-Probe to Webcast Two Upcoming Investor Presentations
FDA Clears First Nucleic Acid Amplification Test to Detect Common Sexually Transmitted Infection Trichomonas Vaginalis
Gen-Probe Announces Webcast of First Quarter 2011 Earnings Conference Call
Gen-Probe to Webcast Three Upcoming Investor Presentations
Gen-Probe Announces $150 Million Stock Repurchase Plan
Gen-Probe Reports Financial Results for the Fourth Quarter and Full Year 2010
Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2010 Earnings Conference Call
Gen-Probe to Webcast Presentation at the 29th Annual J.P. Morgan Healthcare Conference
/R E P E A T -- DiagnoCure signs distribution agreement in the UK for its colorectal cancer test/
/R E P R I S E -- DiagnoCure signe une entente de distribution au Royaume-Uni pour son test du cancer colorectal/

Two Week FREE Trial

iStock Rating

Gen-Probe Incorporated (NASDAQ: GPRO)

Sector: Medical

Company

Community

Analysis

Charts

Analyst

Ratios